This trial is active, not recruiting.

Conditions osteoarthritis, post-traumatic arthritis, avascular necrosis
Treatments smartset hv bone cement, palacos r
Phase phase 4
Sponsor DePuy International
Start date October 2002
End date January 2006
Trial size 36 participants
Trial identifier NCT00208403, CT02/08


The purpose of this study is to monitor the stability of a total hip replacement within the thigh bone when used in artificial hip joints implanted with two different bone cements, SmartSet® HV and Palacos® R, in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be randomly allocated to SmartSet® HV or Palacos® R and will be evaluated at regular intervals following hip surgery using patient, clinical, x-ray assessments and special x-rays which allow the stability of the hip implant to be determined

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification safety/efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose treatment
(Active Comparator)
SmartSet HV
smartset hv bone cement
A high viscosity bone cement for use in total hip replacement
(Active Comparator)
Palacos R
palacos r
A high viscosity bone cement for use in total hip replacement

Primary Outcomes

Distal migration of the femoral prosthesis from the time of implantation to the 2 year follow-up assessment
time frame: 2 Year

Secondary Outcomes

Annual posterior (AP) and medio-lateral (ML) RSA translations
time frame: Annually
Merle D'Aubigne score
time frame: Annually
Radiographic analysis
time frame: Annually

Eligibility Criteria

Male or female participants from 60 years up to 75 years old.

Inclusion Criteria

    Exclusion Criteria

      Additional Information

      Official title Randomised, Prospective, RSA, PMS Study Comparing SmartSet HV & Palacos R in Primary Total Hip Arthroplasty
      Trial information was received from ClinicalTrials.gov and was last updated in September 2011.
      Information provided to ClinicalTrials.gov by DePuy International.